[Effect of vitamin A acid (VAA) on psoriasis. Topical combined therapy using corticoids. Two new VAA preparations for oral administration].
D000284:Administration, Oral; D000305:Adrenal Cortex Hormones / Q000008:administration & dosage / Q000627:therapeutic use*; D000410:Alanine Transaminase / Q000097:blood; D001219:Aspartate Aminotransferases / Q000097:blood; D001799:Blood Sedimentation; D002338:Carotenoids / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D002613:Cheilitis / Q000139:chemically induced; D003967:Diarrhea; D004338:Drug Combinations; D006261:Headache; D006801:Humans; D011278:Pregnanes / Q000008:administration & dosage / Q000627:therapeutic use*; D011565:Psoriasis / Q000188:drug therapy*; D012008:Recurrence
D000305:Adrenal Cortex Hormones; D004338:Drug Combinations; D011278:Pregnanes; D002338:Carotenoids; D001219:Aspartate Aminotransferases; D000410:Alanine Transaminase
Die Wirksamkeit von Vitamin A-Säure (VAS) bei Psoriasis. Ortliche Kombinationsbehandlung mit corticoiden. Zwei neue VAS-Präparate zur peroralen Therapie.